Quantitative analysis of 123I-metaiodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy
- 1 June 1990
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 119 (6), 1329-1337
- https://doi.org/10.1016/s0002-8703(05)80183-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Error of uptake in dual energy acquisition with201TI and123I labeled radiopharmaceuticalsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1990
- Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy.Circulation, 1988
- Recognition of regional hypertrophy in hypertrophic cardiomyopathy using thallium-201 emission-computed tomography: Comparison with two-dimensional echocardiographyThe American Journal of Cardiology, 1984
- THE NORMAL AND ABNORMAL DISTRIBUTION OF THE ADRENOMEDULLARY IMAGING AGENT M-[I-131]IODOBENZYLGUANIDINE (I-131 MIBG) IN MAN - EVALUATION BY SCINTIGRAPHY1983
- Pathogenesis of hypertrophic cardiomyopathy: Hypotheses and speculationsAmerican Heart Journal, 1981
- MYOCARDIAL IMAGING WITH A RADIOIODINATED NOREPINEPHRINE STORAGE ANALOG1981
- RADIOLABELED ADRENERGIC NEURON-BLOCKING AGENTS - ADRENOMEDULLARY IMAGING WITH [I-131]IODOBENZYLGUANIDINE1980
- Hypertrophic cardiomyopathy. Evaluation by gated cardiac blood pool scanning.Circulation, 1977
- Idiopathic Hypertrophic Subaortic Stenosis: Detection by Thallium 201 Myocardial Perfusion ImagingNew England Journal of Medicine, 1975
- Prospects and Predictions for the CardiomyopathiesCirculation, 1974